Please provide your email address to receive an email when new articles are posted on . Mucosal melanoma — or melanoma in the mucous membranes — differs from cutaneous melanoma in its genesis, its ...

Scientists headed by a team at the University of Tokyo have identified a protein, known as podoplanin (PDPN), that is common to both human and canine mucosal melanoma, and which appears to mobilize ...

Nemvaleukin alfa is an investigational, engineered fusion protein consisting of modified interleukin-2 (IL-2) and the high-affinity IL-2 alpha receptor chain. The Food and Drug Administration (FDA) ...

"There are many other factors that could possibly contribute to better or worse prognosis for patients with mucosal melanoma, including mutational status of genes like BRAF." — Kathleen M. Mulligan, ...

Although rare, mucosal melanoma in humans has a low survival rate. It has been difficult to investigate due to a lack of similar cancers in animals for study. Researchers explored a protein common to ...

Lifileucel showed a 50% objective response rate in advanced mucosal melanoma patients post-immune checkpoint inhibitor progression, with durable responses in four of six responders. Advanced mucosal ...

A retrospective study on the combination of a vascular endothelial growth factor receptor inhibitor plus programmed cell death-1 blockade added to evidence of efficacy in early trials. The combination ...

J.B. Ward's experience highlights the importance of self-advocacy in managing rare cancers, emphasizing the need for patients to seek multiple opinions and question medical advice. Mucosal melanoma is ...

Not all melanomas are created equal. While most melanomas appear on the skin as the result of sun exposure, a small subset of melanomas arise spontaneously from mucosal tissues. And while targeted ...

Relationship between dose, exposure, and antitumoral activity of sorafenib in melanoma. Background: Mucosal melanoma is a rare but aggressive subtype of melanoma whose clinicopathologic ...